A total of 21 patients suffering from drug-induced rashes from practolol have been seen over the past two years. The clinical manifestations varied, with the morphological appearances of the rash resembling those of eczema, lupus erythematosus, lichen planus, and a highly characteristic toxic erythematous psoriasiform eruption. Persistent ocular damage was a feature in three cases.
adenomas and one (who was taking the oral contraceptive) had a lump caused by fatty tissue and fibrosis. In contrast, prolactin concentrations were not raised in the 20 other premenopausal patients in this series who had fibroadenomas.
Both postmenopausal patients with benign lesions and raised prolactin concentrations had duct ectasia. This histological diagnosis was also made in two other postmenopausal patients whose prolactin concentrations were normal. The one patient with malignant disease and hyperprolactinaemia had an adenocarcinoma.
Discussion
When the patients with benign and malignant diseases of the breast were divided into groups according to their reproductive status there was a significant difference in the incidence of hyperprolactinaemia between the whole group of premenopausal patients and the whole group of postmenopausal patients. It therefore seems important to consider the reproductive status in any study relating to prolactin measurements in patients with benign and malignant disease of the breast.
Our results do not support the theory of an aetiological relationship between hyperprolactinaemia and breast cancer. Furthermore, analysis of the histological findings in the benign lumps in the patients with and without hyperprolactinaemia does not provide support for an aetiological role of prolactin in this condition either.
Finally, it remains to consider the cause of the hyperprolactinaemia in the seven patients who had levels above 25 ng/ml. Pituitary tumours in these patients were unlikely since skull x-ray examinations showed nothing abnormal. None was receiving tranquillizers or other drugs thought to raise prolactin levels. Stress, both physical and psychological (Frantz et al., 1972; Friesen et al., 1972) , can raise prolactin concentrations. Possibly the cause of the hyperprolactinaemia in these patients was the psychological stress associated with the fear of surgery for a lump in the breast. These findings emphasize the need for a strictly matched control group in evaluating hormonal profiles in patients with cancer. We suggest that in the case of carcinoma of the breast patients with benign breast disease form the most (Sandler and Clayton, 1970; George et al., 1970) , but the number of patients treated was small and each trial lasted only 12 weeks. In a survey of 2,100 patients who were taking practolol seven patients were found to have developed a micropapular, eczematous, or urticarial rash (Wiseman, 1971) . Practolol can also induce a syndrome similar to lupus erythematosus (L.E.) the symptoms of which are fever, polyarthritis, and an erythematous rash, associated with positive results of tests for L.E. cells and antinuclear factor (Raftery and Denman, 1973) .
Since the report of a patient with exfoliative dermatitis produced by practolol (Rowland and Stevenson, 1972) an increasing number of patients have been referred to us with a rash which was later found to be caused by this drug. Though some of the patients presented with eczematous or lichenoid rashes most presented with a distinctive psoriasiform eruption which, we feel, produces an easily recognizable diagnostic picture.
Patients
Twenty-one patients (nine men, 12 women) ranging in age from 45 to 78 years were seen in the skin department. Each patient was taking 100-600 mg of practolol daily (see (Felix and Comaish, 1974) .
ORAL CHALLENGE
Twelve of the patients agreed to oral challenge with practolol. They were told to take one tablet (100 mg) every 12 hours and to report immediately if any reaction developed. Nine patients reported after 36 hours, one (case 20) after four days, and one (case 14) after five days. Each patient first noticed itching followed by the appearance ofan erythematous macular eruption. The patient in case 14 was rechallenged one month later and developed itching with a widespread erythematous macular eruption four hours after taking one tablet of practolol.
One patient (case 11) developed an erythematous scaly eruption confined largely to the elbows and knees four weeks after the start of the challenge. The distribution of the rash was identical to the original psoriasiform eruption. One of the patients (case 18) who developed a lichenoid eruption was challenged and complained of an itchy erythematous rash which was confined precisely to the sites of the original rash. No adverse systemic effects developed in any of these patients.
LABORATORY INVESTIGATIONS
Antinuclear factor was present in the serum of five of the 18 patients tested, and L.E. cells were found in one patient. In one patient the antinuclear factor was present for 16 months after practolol was stopped, while in the remaining four patients it persisted for four to six weeks. Serum samples taken from the patients positive for antinuclear factor were estimated for anti-DNA antibodies and the results were found to be within normal limits.
HISTOLOGY AND IMMUNOFLUORESCENCE
Histological specimens were obtained from 10 patients. All sections stained with haematoxylin and eosin showed essentially similar and diagnostic changes though they varied in degree depending on whether the clinical picture was psoriasiform, eczematous, or lichenoid.
The most striking changes were seen in those sections simulating lichen planus where there was atrophy of the epidermis with the production of large numbers of colloid bodies representing dead epidermal cells migrating through the epidermis and settling in the outer horny layer. In the other clinical groups this feature was less florid, but in all cases, regardless of clinical appearance, periodic-acid Schiff stains showed marked patchy swelling and disruption of the basement membrane as seen in cases of lichen planus or lupus erythematosus.
Skin biopsy specimens from eight patients were examined by immunofluorescence for the presence of bound immunoglobulins (IgG, IgM, and IgA) and complement (C3). Very fine granular deposits of IgG, IgM, and C3 were present along the dermoepidermal junction in six patients. The immunofluorescence findings resembled in some ways those found in L.E., but the granular pattern was much finer than is usually seen in this condition. A more detailed description of the histological and immunofluorescent patterns will be the subject of a further report.
Discussion
Identification of the culprit in suspected drug reactions is often handicapped by the absence of a specific in-vitro test. Patch and intradermal testing were of little value in these patients, and oral challenge, which was considered justifiable, provided proof of the association in all 12 patients tested. Withdrawal of the drug produced a rapid resolution of skin problems in all patients, and no recurrence was seen on instituting alternative betablockade therapy. Zacharias (1972) reported that 16 out of 156 patients developed slowly progressive chronic skin reactions which appeared to be of a mixed eczematous and psoriatic nature. In our 21 patients 14 presented with a distinctive picture of a psoriasiform eruption which was most marked over bony prominences, invariably preceded by hyperkeratotic changes on the palms, soles, and sides of the fingers, and followed by an erythematous scaling, marginated rash involving other areas of the body. The full clinical picture tended to develop over several months. In only two of our patients was there a previous history of psoriasis, and we have no evidence that pre-existing psoriasis is aggravated by practolol. Despite the psoriasiform appearance of the eruption the histology never suggested true psoriasis. The slow evolution of this psoriasiform type of rash is in marked contrast to the acuteness of the lichenoid, L.E.-like, and erythrodermatous reactions.
Five of our patients (24%) had antinuclear factor in the serum whereas Raftery (1972) reported an incidence of 3%-4% in all patients on practolol. There were two patients with arthropathy who were positive for antinuclear factor, while six patients showed some histological features compatible with a diagnosis of lupus erythematosus. The one patient with polyserositis was negative for antinuclear factor and L.E. cell phenomenon were absent. In four patients with a positive response antinuclear factor persisted for two to three months after practolol had been stopped, which is in keeping with a diagnosis of drug-induced systemic lupus erythematosus (S.L.E.) (Bodman et al., 1967; Alarcon-Segovia, 1969 Three of our patients had sore dry eyes as reported by Wright (1974) , and tear secretion was found to be diminished in two on formal testing. The third patient developed bilateral corneal ulcers. In all three patients eye symptoms were still present at the time of writing despite drug withdrawal, and the ophthalmological problems may well prove to be the most serious aspect of this drug-induced syndrome. A strong case can be made for performing routine Schirmer's tear secretion tests at regular intervals during practolol therapy.
The mechanism whereby this drug reaction occurs has yet to be clarified. We have probably excluded immediate-and delayed-type allergies. It is possible that since practolol acts as a partial sympathomimetic agonist it will stimulate cyclic adenosine monophosphate activity. This in turn may have some direct effect on epidermal cells or, as Raftery and Denman (1973) suggested, impairthe activity of T-lymphocyte populations, resulting in the production of strains of lymphocytes with autoimmune propensities. It is of interest that a histological picture closely resembling that seen in our patients has been reported in a patient with lichen planus associated with thymoma (Tan, 1974) .
Further studies of cell dynamics in patients with practolol reactions are in progress.
Introduction
About 40 unstable haemoglobins have now been described (Lehmann, 1974) . A few were discovered by chance, and we report such a haemoglobin found in the course of routine investigation of a long-stay psychiatric patient.
Case Report A 42-year-old Caucasian man had for the past 15 years been confined to hospital with paranoid schizophrenia. His history included appendi-
